Missing/wrong data?
Log in to edit
A phase II study of cediranib (AZD 2171) in treatment naive patients with progressive unresectable recurrent or metastatic renal cell carcinoma. A trial of the PMH phase 2 consortium
scientific article published on January 26, 2013
Author/s
author: Ian F. Tannock, Masoom A Haider, Christian Kollmannsberger
Work details
Publication date
January 26, 2013
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.